Pharming Group (PHAR) Stock Chart & Stock Price History → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free PHAR Stock Alerts $9.59 -0.04 (-0.42%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Pharming Group Stock Price Performance5 Day Performance-4.15%1 Month Performance-5.00%3 Month Performance-14.42%6 Month Performance-16.65%Year-To-Date Performance-16.14%1 Year Performance-18.98% Receive PHAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development PHAR Stock Chart for Thursday, May, 16, 2024 PHAR Chart by TradingView Pharming Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$9.63$9.59-0.42%$9.59$9.281,816 shs$645.79 million05/14/2024$9.40$9.63+2.45%$9.64$9.283,323 shs$648.48 million05/13/2024$10.00$9.40-6.00%$9.62$9.341,432 shs$633.00 million05/10/2024$9.54$10.00+4.82%$10.20$9.402,926 shs$671.10 million05/09/2024$9.50$9.54+0.42%$9.69$9.531,057 shs$640.23 million05/08/2024$9.62$9.50-1.25%$9.53$9.501,420 shs$637.55 million Get the Latest News and Ratings for PHAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$9.64$9.62-0.21%$9.66$9.56428 shs$645.60 million05/06/2024$10.00$9.64-3.60%$9.95$9.591,880 shs$646.94 million05/03/2024$10.00$10.00+0.00%$10.00$9.371,529 shs$671.10 million05/02/2024$10.45$10.00-4.31%$10.00$9.373,334 shs$671.09 million05/01/2024$9.39$10.45+11.29%$10.45$9.801,078 shs$701.30 million04/30/2024$9.36$9.39+0.32%$9.77$9.361,158 shs$630.16 million04/29/2024$9.80$9.36-4.49%$9.91$9.361,264 shs$628.15 million04/26/2024$9.60$9.61+0.10%$9.94$9.531,703 shs$644.93 million04/25/2024$9.89$9.60-2.93%$10.71$9.434,437 shs$644.26 million04/24/2024$9.68$9.89+2.22%$9.89$9.632,744 shs$663.72 million04/23/2024$9.92$9.68-2.47%$9.78$9.60794 shs$649.29 million04/22/2024$10.00$9.92-0.80%$9.95$9.92889 shs$665.73 million04/19/2024$9.62$9.85+2.44%$10.18$9.336,272 shs$661.03 million04/18/2024$10.17$9.62-5.46%$9.70$9.273,543 shs$645.23 million04/17/2024$10.09$10.17+0.79%$10.55$10.019,820 shs$682.51 million04/16/2024$10.21$10.09-1.18%$10.17$10.071,978 shs$677.14 million04/15/2024$10.53$10.21-3.04%$10.78$10.211,196 shs$685.19 million04/12/2024$11.21$10.50-6.33%$10.82$10.501,338 shs$704.66 million04/11/2024$10.48$11.21+6.97%$11.30$10.753,522 shs$752.30 million04/10/2024$10.00$10.48+4.80%$10.48$10.48728 shs$703.31 million04/09/2024$10.66$10.00-6.19%$10.65$10.0011,762 shs$671.11 million04/08/2024$10.60$10.66+0.57%$10.67$10.65372 shs$715.36 million04/05/2024$11.02$10.60-3.81%$10.76$10.60616 shs$711.37 million04/04/2024$10.84$11.02+1.66%$11.02$10.69441 shs$739.52 million04/03/2024$10.76$10.84+0.74%$10.96$10.81312 shs$727.47 million04/02/2024$11.29$10.76-4.66%$10.93$10.761,171 shs$722.10 million04/01/2024$10.84$11.29+4.11%$11.29$10.551,975 shs$757.36 million03/29/2024$10.84$10.84$10.84$10.84476 shs$727.44 million03/28/2024$10.84$10.84$10.84$10.84476 shs$727.47 million03/27/2024$10.83$10.84+0.09%$10.85$10.791,164 shs$727.47 million03/26/2024$11.27$10.83-3.90%$11.20$10.83928 shs$726.80 million03/25/2024$11.27$11.27$11.27$11.27457 shs$756.33 million03/22/2024$11.00$11.23+2.09%$11.27$11.21239 shs$753.65 million03/21/2024$11.00$11.00$11.00$11.001,237 shs$738.21 millionA ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now.03/20/2024$11.00$11.00$11.00$11.00458 shs$738.21 million03/19/2024$11.35$11.00-3.08%$11.32$10.721,817 shs$738.18 million03/18/2024$11.49$11.35-1.21%$11.80$10.719,743 shs$761.70 million03/15/2024$10.92$11.48+5.13%$11.50$11.342,653 shs$770.42 million03/14/2024$11.11$10.92-1.71%$11.07$10.924,880 shs$732.81 million03/13/2024$11.88$11.11-6.48%$11.77$11.111,151 shs$745.59 million03/12/2024$11.65$11.88+1.97%$11.94$11.88979 shs$797.27 million03/11/2024$11.51$11.65+1.26%$11.65$11.481,444 shs$781.83 million03/08/2024$11.39$11.51+1.01%$11.61$11.51865 shs$772.10 million03/07/2024$11.20$11.39+1.70%$11.39$11.39474 shs$764.38 million03/06/2024$11.16$11.20+0.36%$11.20$11.20951 shs$751.63 million03/05/2024$11.10$11.16+0.54%$11.90$10.888,192 shs$748.91 million03/04/2024$11.37$11.10-2.36%$12.20$10.3812,666 shs$744.92 million03/01/2024$11.45$11.00-3.93%$11.37$11.00466 shs$738.21 million02/29/2024$11.10$11.45+3.15%$11.45$11.184,721 shs$768.41 million02/28/2024$11.16$11.10-0.54%$11.44$10.742,181 shs$744.92 million02/27/2024$11.28$11.16-1.06%$11.60$11.161,509 shs$748.95 million02/26/2024$11.75$11.28-4.00%$11.28$11.28657 shs$757.00 million02/23/2024$11.19$11.39+1.79%$11.39$11.3995 shs$764.38 million02/22/2024$11.14$11.19+0.46%$12.00$11.143,936 shs$750.96 million02/21/2024$11.01$11.14+1.17%$11.50$10.955,853 shs$747.56 million02/20/2024$11.20$11.01-1.70%$11.80$11.005,234 shs$738.85 million02/19/2024$11.20$11.20$12.00$11.031,800 shs$751.63 million02/16/2024$11.05$11.20+1.36%$12.00$11.031,808 shs$751.63 million02/15/2024$11.56$11.05-4.41%$12.18$11.034,693 shs$741.53 million Related Companies: ZYME Stock Chart LYEL Stock Chart ORIC Stock Chart OLMA Stock Chart GHRS Stock Chart SLN Stock Chart STOK Stock Chart CVAC Stock Chart CALT Stock Chart PAHC Stock Chart Receive PHAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHAR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.